The Filings Report

DocuSign, Inc. Common Stock

DOCUNasdaqCIK 1261333Technology / Softwarefiscal year ends January38 quarters since 2017

Revenue, Q2 FY2027
$876M
+9.4% on Q2 FY2026
Net income
$78M
+23.4% on Q2 FY2026
Free cash flow
$296M
+35.9% on Q2 FY2026
Diluted EPS
$0.40
+33.3% on Q2 FY2026
Revenue, TTM
$3.4B
trailing four quarters
Net margin, TTM
9.8%
net income $330M
Free cash flow, TTM
$1.2B
$1.3B less $125M capex
Cash and equivalents
$528M
long-term debt —, Jul 31, 2026
Shares, 12-month change
−7.1%
187M shares, Jul 31, 2026
Buybacks, TTM
$1.1B
7.3% of market value
Dividends, TTM
—
no yield
Market value
$15.3B
at the close, buybacks

Latest quarter Q2 FY2027, filed September 4, 2026. Trailing figures sum the latest four quarters. Market values at the latest close, from a market data vendor.

In Q2 FY2027, the quarter ended July 31, 2026, DocuSign, Inc. Common Stock reported revenue of $876M, +9.4% on Q2 FY2026, and net income of $78M (+23.4%). Operating margin was 13.4%. Free cash flow, operating cash flow less capital expenditures, was $296M ($335M less $39M). Diluted earnings per share were $0.40.

The last 16 quarters

Q3 FY2023 to Q2 FY2027, through the filing of September 4, 2026.

Revenue and net incomeRevenueNet income
−$250M$0$250M$500M$750M$1.0BQ3'23, Revenue: $645MQ3'23, Net income: −$30MQ3'23Q4'23, Revenue: $660MQ4'23, Net income: $5MQ4'23Q1'24, Revenue: $661MQ1'24, Net income: $539KQ1'24Q2'24, Revenue: $688MQ2'24, Net income: $7MQ2'24Q3'24, Revenue: $700MQ3'24, Net income: $39MQ3'24Q4'24, Revenue: $712MQ4'24, Net income: $27MQ4'24Q1'25, Revenue: $710MQ1'25, Net income: $34MQ1'25Q2'25, Revenue: $736MQ2'25, Net income: $888MQ2'25Q3'25, Revenue: $755MQ3'25, Net income: $62MQ3'25Q4'25, Revenue: $776MQ4'25, Net income: $83MQ4'25Q1'26, Revenue: $764MQ1'26, Net income: $72MQ1'26Q2'26, Revenue: $801MQ2'26, Net income: $63MQ2'26Q3'26, Revenue: $818MQ3'26, Net income: $84MQ3'26Q4'26, Revenue: $837MQ4'26, Net income: $90MQ4'26Q1'27, Revenue: $830MQ1'27, Net income: $78MQ1'27Q2'27, Revenue: $876MQ2'27, Net income: $78MQ2'27−$250M$0$250M$500M$750M$1.0BQ3'23, Revenue: $645MQ3'23, Net income: −$30MQ4'23, Revenue: $660MQ4'23, Net income: $5MQ4'23Q1'24, Revenue: $661MQ1'24, Net income: $539KQ2'24, Revenue: $688MQ2'24, Net income: $7MQ2'24Q3'24, Revenue: $700MQ3'24, Net income: $39MQ4'24, Revenue: $712MQ4'24, Net income: $27MQ4'24Q1'25, Revenue: $710MQ1'25, Net income: $34MQ2'25, Revenue: $736MQ2'25, Net income: $888MQ2'25Q3'25, Revenue: $755MQ3'25, Net income: $62MQ4'25, Revenue: $776MQ4'25, Net income: $83MQ4'25Q1'26, Revenue: $764MQ1'26, Net income: $72MQ2'26, Revenue: $801MQ2'26, Net income: $63MQ2'26Q3'26, Revenue: $818MQ3'26, Net income: $84MQ4'26, Revenue: $837MQ4'26, Net income: $90MQ4'26Q1'27, Revenue: $830MQ1'27, Net income: $78MQ2'27, Revenue: $876MQ2'27, Net income: $78MQ2'27

Net income losses drawn in red.

Free cash flow
$0$100M$200M$300M$400MQ3'23, Free cash flow: $36MQ3'23Q4'23, Free cash flow: $113MQ4'23Q1'24, Free cash flow: $215MQ1'24Q2'24, Free cash flow: $184MQ2'24Q3'24, Free cash flow: $240MQ3'24Q4'24, Free cash flow: $249MQ4'24Q1'25, Free cash flow: $232MQ1'25Q2'25, Free cash flow: $198MQ2'25Q3'25, Free cash flow: $211MQ3'25Q4'25, Free cash flow: $280MQ4'25Q1'26, Free cash flow: $228MQ1'26Q2'26, Free cash flow: $218MQ2'26Q3'26, Free cash flow: $263MQ3'26Q4'26, Free cash flow: $350MQ4'26Q1'27, Free cash flow: $289MQ1'27Q2'27, Free cash flow: $296MQ2'27$0$100M$200M$300M$400MQ3'23, Free cash flow: $36MQ4'23, Free cash flow: $113MQ4'23Q1'24, Free cash flow: $215MQ2'24, Free cash flow: $184MQ2'24Q3'24, Free cash flow: $240MQ4'24, Free cash flow: $249MQ4'24Q1'25, Free cash flow: $232MQ2'25, Free cash flow: $198MQ2'25Q3'25, Free cash flow: $211MQ4'25, Free cash flow: $280MQ4'25Q1'26, Free cash flow: $228MQ2'26, Free cash flow: $218MQ2'26Q3'26, Free cash flow: $263MQ4'26, Free cash flow: $350MQ4'26Q1'27, Free cash flow: $289MQ2'27, Free cash flow: $296MQ2'27

Operating cash flow less capital expenditures; negative quarters in red.

Cash and equivalents against long-term debtCash and equivalentsLong-term debt
$0$500M$1.0B$1.5BQ3'23, Cash and equivalents: $633MQ3'23Q4'23, Cash and equivalents: $722MQ4'23Q1'24, Cash and equivalents: $940MQ1'24Q2'24, Cash and equivalents: $1.0BQ2'24Q3'24, Cash and equivalents: $1.2BQ3'24Q4'24, Cash and equivalents: $797MQ4'24Q1'25, Cash and equivalents: $817MQ1'25Q2'25, Cash and equivalents: $619MQ2'25Q3'25, Cash and equivalents: $611MQ3'25Q4'25, Cash and equivalents: $649MQ4'25Q1'26, Cash and equivalents: $657MQ1'26Q2'26, Cash and equivalents: $600MQ2'26Q3'26, Cash and equivalents: $583MQ3'26Q4'26, Cash and equivalents: $602MQ4'26Q1'27, Cash and equivalents: $548MQ1'27Q2'27, Cash and equivalents: $528MQ2'27$0$500M$1.0B$1.5BQ3'23, Cash and equivalents: $633MQ4'23, Cash and equivalents: $722MQ4'23Q1'24, Cash and equivalents: $940MQ2'24, Cash and equivalents: $1.0BQ2'24Q3'24, Cash and equivalents: $1.2BQ4'24, Cash and equivalents: $797MQ4'24Q1'25, Cash and equivalents: $817MQ2'25, Cash and equivalents: $619MQ2'25Q3'25, Cash and equivalents: $611MQ4'25, Cash and equivalents: $649MQ4'25Q1'26, Cash and equivalents: $657MQ2'26, Cash and equivalents: $600MQ2'26Q3'26, Cash and equivalents: $583MQ4'26, Cash and equivalents: $602MQ4'26Q1'27, Cash and equivalents: $548MQ2'27, Cash and equivalents: $528MQ2'27

Positions at each quarter end, as filed; short-term investments are not included.

Income statement

Last eight quarters, newest first, through Q2 FY2027 filed September 4, 2026.

DocuSign, Inc. Common Stock income statement, quarterly
Millions of dollarsQ2 FY2027ended Jul 31, 2026filed Sep 4, 2026Q1 FY2027ended Apr 30, 2026filed Jun 5, 2026Q4 FY2026ended Jan 31, 2026filed Mar 18, 2026Q3 FY2026ended Oct 31, 2025filed Dec 5, 2025Q2 FY2026ended Jul 31, 2025filed Sep 5, 2025Q1 FY2026ended Apr 30, 2025filed Jun 6, 2025Q4 FY2025ended Jan 31, 2025filed Mar 18, 2025Q3 FY2025ended Oct 31, 2024filed Dec 6, 2024YoYQ2 FY2027vs Q2 FY2026
Revenue876830837818801764776755+9.4%
Cost of revenue178171170171165157160157+7.5%
Gross profit698659667648635606616598+9.9%
Research and development164160168168170159155151−3.6%
Selling, general and administrative103921069895909998+8.3%
Operating income118111888565606059+80.3%
Other income (expense)8714111214813−34.3%
Pretax income1251181029676746872+63.5%
Income tax47401112132(16)9+250.3%
Net income7878908463728362+23.4%
Diluted EPS ($)0.400.40—0.400.300.34—0.30+33.3%
Diluted shares (millions)193196—208211213—209—

Fourth quarters are the fiscal year less the first nine months when the filer reports no discrete fourth quarter, and are marked. Diluted EPS is never derived, so a derived quarter shows none. Italic figures are derived.

Balance sheet

Last eight quarters, newest first, through Q2 FY2027 filed September 4, 2026.

DocuSign, Inc. Common Stock balance sheet, quarterly
Millions of dollarsQ2 FY2027ended Jul 31, 2026filed Sep 4, 2026Q1 FY2027ended Apr 30, 2026filed Jun 5, 2026Q4 FY2026ended Jan 31, 2026filed Mar 18, 2026Q3 FY2026ended Oct 31, 2025filed Dec 5, 2025Q2 FY2026ended Jul 31, 2025filed Sep 5, 2025Q1 FY2026ended Apr 30, 2025filed Jun 6, 2025Q4 FY2025ended Jan 31, 2025filed Mar 18, 2025Q3 FY2025ended Oct 31, 2024filed Dec 6, 2024YoYQ2 FY2027vs Q2 FY2026
Cash and equivalents528548602583600657649611−12.0%
Short-term investments—————————
Total current assets1,2691,2561,4911,3071,3191,3771,4891,332−3.8%
Total assets3,9613,9844,2303,9823,9503,9474,0133,770+0.3%
Total current liabilities1,9731,8892,0391,7841,7761,7411,8321,599+11.1%
Long-term debt—————————
Total liabilities2,2422,1642,3122,0011,9621,9332,0101,781+14.3%
Stockholders’ equity1,7191,8201,9181,9821,9882,0152,0031,989−13.6%
Shares outstanding (millions)187191194200201202202202—

Positions at each period end. Nothing on this statement is derived. Long-term debt is the filed noncurrent line only; no total-debt composite is constructed across filers. Italic figures are derived.

Cash flow statement

Last eight quarters, newest first, through Q2 FY2027 filed September 4, 2026.

DocuSign, Inc. Common Stock cash flow statement, quarterly
Millions of dollarsQ2 FY2027ended Jul 31, 2026filed Sep 4, 2026Q1 FY2027ended Apr 30, 2026filed Jun 5, 2026Q4 FY2026ended Jan 31, 2026filed Mar 18, 2026Q3 FY2026ended Oct 31, 2025filed Dec 5, 2025Q2 FY2026ended Jul 31, 2025filed Sep 5, 2025Q1 FY2026ended Apr 30, 2025filed Jun 6, 2025Q4 FY2025ended Jan 31, 2025filed Mar 18, 2025Q3 FY2025ended Oct 31, 2024filed Dec 6, 2024YoYQ2 FY2027vs Q2 FY2026
Operating cash flow335322377290246251308234+36.0%
Capital expenditures3932272728242824+36.5%
Free cash flow (CFO − capex)296289350263218228280211+35.9%
Depreciation and amortization3432263029302928+17.0%
Share repurchases307318269215202183162173+52.1%
Dividends paid—————————

10-Qs file cash flows as year-to-date totals, so quarterly figures are differenced from consecutive filings and marked. Free cash flow is operating cash flow less capital expenditures, computed from the two filed lines. Italic figures are derived.

Annual statements

Every fiscal year filed, newest first, through FY2026 filed March 18, 2026.

Income statement

DocuSign, Inc. Common Stock income statement, annual
Millions of dollarsFY2026ended Jan 31, 2026filed Mar 18, 2026FY2025ended Jan 31, 2025filed Mar 18, 2025FY2024ended Jan 31, 2024filed Mar 21, 2024FY2023ended Jan 31, 2023filed Mar 27, 2023FY2022ended Jan 31, 2022filed Mar 25, 2022FY2021ended Jan 31, 2021filed Mar 31, 2021FY2020ended Jan 31, 2020filed Mar 27, 2020FY2019ended Jan 31, 2019filed Mar 26, 2019FY2018ended Jan 31, 2018filed Jun 8, 2018FY2017ended Jan 31, 2017filed Mar 26, 2019
Revenue3,2202,9772,7622,5162,1071,453974701519381
Cost of revenue663622573536466364243192118102
Gross profit2,5562,3552,1891,9801,6411,089731509400279
Research and development6655885394813932721861869290
Selling, general and administrative3893764203162331931472098264
Operating income29920032(88)(62)(174)(194)(426)(52)(116)
Other income (expense)51506951919931
Pretax income34724894(90)(67)(229)(204)(428)(49)(115)
Income tax38(820)2083145(2)30
Net income3091,06874(97)(70)(243)(208)(426)(52)(115)
Diluted EPS ($)1.485.080.36(0.49)(0.36)(1.31)(1.18)———
Diluted shares (millions)209210209201197186177———

Balance sheet

DocuSign, Inc. Common Stock balance sheet, annual
Millions of dollarsFY2026ended Jan 31, 2026filed Mar 18, 2026FY2025ended Jan 31, 2025filed Mar 18, 2025FY2024ended Jan 31, 2024filed Mar 21, 2024FY2023ended Jan 31, 2023filed Mar 27, 2023FY2022ended Jan 31, 2022filed Mar 25, 2022FY2021ended Jan 31, 2021filed Mar 31, 2021FY2020ended Jan 31, 2020filed Mar 27, 2020FY2019ended Jan 31, 2019filed Mar 26, 2019FY2018ended Jan 31, 2018filed Jun 8, 2018FY2017ended Jan 31, 2017filed Mar 26, 2019
Cash and equivalents602649797722509566241518257—
Short-term investments———3102942074152510—
Total current assets1,4911,4891,5681,6311,3201,162944985419—
Total assets4,2304,0132,9713,0132,5412,3371,8911,615620—
Total current liabilities2,0391,8321,6612,2081,3721,093694516374—
Long-term debt——————————
Total liabilities2,3122,0101,8422,3952,2662,0071,3451,001411—
Stockholders’ equity1,9182,0031,130617276326546614(339)(347)
Shares outstanding (millions)194202205202199193181170157—

Cash flow statement

DocuSign, Inc. Common Stock cash flow statement, annual
Millions of dollarsFY2026ended Jan 31, 2026filed Mar 18, 2026FY2025ended Jan 31, 2025filed Mar 18, 2025FY2024ended Jan 31, 2024filed Mar 21, 2024FY2023ended Jan 31, 2023filed Mar 27, 2023FY2022ended Jan 31, 2022filed Mar 25, 2022FY2021ended Jan 31, 2021filed Mar 31, 2021FY2020ended Jan 31, 2020filed Mar 27, 2020FY2019ended Jan 31, 2019filed Mar 26, 2019FY2018ended Jan 31, 2018filed Jun 8, 2018FY2017ended Jan 31, 2017filed Mar 26, 2019
Operating cash flow1,1651,0179805075062971167655(5)
Capital expenditures106979278618272301943
Free cash flow (CFO − capex)1,059920887429445215444636(48)
Depreciation and amortization1161089586827150383228
Share repurchases8696841466300————
Dividends paid——————————

Insider activity

Form 4 filings by officers, directors and 10% owners, November 3, 2024 to November 3, 2026. Only open-market purchases and sales count as buys and sells; awards, exercises, tax withholding and gifts are listed in grey and never counted.

Bought, three months
$0
0 purchases by 0 insiders; officers and directors $0
Sold, three months
$14M
24 sales by 10 insiders; officers and directors $14M
Bought, twelve months
$0
0 purchases by 0 insiders; officers and directors $0
Sold, twelve months
$26M
78 sales by 10 insiders; officers and directors $26M

The last 25 transactions

TradedInsiderRoleTransactionSharesPriceValueHeld afterFiled
Nov 2, 2026Trollope Rowan MDirectoroption exercise870$0.00—1,739Nov 3, 2026
Nov 2, 2026Hansen PaulaChief Revenue Officeropen-market sale10b5-13,300$81.82$270K103,258Nov 3, 2026
Oct 5, 2026Hansen PaulaChief Revenue Officeraward1$40.84$41106,558Nov 3, 2026
Oct 1, 2026Hansen PaulaChief Revenue Officeropen-market sale10b5-13,000$68.75$206K106,857Oct 2, 2026
Oct 1, 2026Hansen PaulaChief Revenue Officeropen-market sale10b5-1300$69.37$21K106,557Oct 2, 2026
Oct 1, 2026Shaughnessy James PChief Legal Officeropen-market sale10b5-111,600$68.77$798K50,991Oct 2, 2026
Oct 1, 2026Shaughnessy James PChief Legal Officeropen-market sale10b5-1400$69.55$28K50,591Oct 2, 2026
Oct 1, 2026Thygesen Allan C.President and CEO, Directoropen-market sale10b5-17,475$68.53$512K185,576Oct 2, 2026
Oct 1, 2026Thygesen Allan C.President and CEO, Directoropen-market sale10b5-113,598$69.45$944K171,978Oct 2, 2026
Oct 1, 2026Thygesen Allan C.President and CEO, Directoropen-market sale10b5-15,177$69.98$362K166,801Oct 2, 2026
Oct 1, 2026Wilderotter Mary AgnesDirectoropen-market sale10b5-11,000$68.80$69K2,199Oct 2, 2026
Sep 17, 2026Chatwani RobertPresident General Mgr, Growthopen-market sale10b5-14,044$68.77$278K86,560Sep 21, 2026
Sep 17, 2026Chatwani RobertPresident General Mgr, Growthopen-market sale10b5-110,632$69.66$741K75,928Sep 21, 2026
Sep 16, 2026Wilderotter Mary AgnesDirectoropen-market sale10b5-11,096$70.60$77K3,199Sep 16, 2026
Sep 15, 2026Shaughnessy James PChief Legal Officeroption exercise18,277$0.00—71,092Sep 21, 2026
Sep 15, 2026Shaughnessy James PChief Legal Officertax withholding8,501$0.00—62,591Sep 21, 2026
Sep 15, 2026Chatwani RobertPresident General Mgr, Growthoption exercise35,307$0.00—108,112Sep 16, 2026
Sep 15, 2026Chatwani RobertPresident General Mgr, Growthtax withholding17,508$0.00—90,604Sep 16, 2026
Sep 15, 2026Thygesen Allan C.President and CEO, Directoroption exercise67,467$0.00—226,505Sep 16, 2026
Sep 15, 2026Thygesen Allan C.President and CEO, Directortax withholding33,454$0.00—193,051Sep 16, 2026
Sep 15, 2026Grayson Blake JeffreyChief Financial Officeroption exercise44,234$0.00—125,663Sep 16, 2026
Sep 15, 2026Grayson Blake JeffreyChief Financial Officertax withholding17,730$0.00—107,933Sep 16, 2026
Sep 15, 2026Shaughnessy James PChief Legal Officeroption exercise18,277$0.00—71,092Sep 16, 2026
Sep 15, 2026Shaughnessy James PChief Legal Officertax withholding11,983$0.00—59,109Sep 16, 2026
Sep 15, 2026Hansen PaulaChief Revenue Officeroption exercise39,444$0.00—129,416Sep 16, 2026

Full insider history for DocuSign, Inc. Common Stock, or insider activity across all companies. A record of filings, not a recommendation.

Sources

Fiscal year ends in month 1; periods are labeled with the issuer's own fiscal calendar. Values are as most recently filed (restatements apply; per-share values are on current split basis per the connector's split table, flagged in adjusted). Flow items flagged in `derived` were computed (Q4 = FY − nine months; quarterly cash flow differenced from year-to-date filings) rather than read from a filing. `reconciliation.repaired` lists periods where a full-year figure was filed in a quarter slot: that row was dropped and the quarter rebuilt from the annual figure. `reconciliation.quarantined` lists periods where four filed quarters do not sum to the filed year — those quarterly values are withheld, so a blank there is a withholding rather than an absence of reporting.

Filer
DOCUSIGN, INC., CIK 1261333 on EDGAR
Extract generated
November 4, 2026
Withheld
none
Repaired
none
XBRL concepts behind each line

Income statement

Revenue: RevenueFromContractWithCustomerExcludingAssessedTax
Cost of revenue: CostOfGoodsAndServicesSold
Gross profit: GrossProfit
Research and development: ResearchAndDevelopmentExpense
Selling, general and administrative: GeneralAndAdministrativeExpense
Operating income: OperatingIncomeLoss
Other income (expense): NonoperatingIncomeExpense
Pretax income: IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
Income tax: IncomeTaxExpenseBenefit
Net income: NetIncomeLoss
Diluted EPS ($): EarningsPerShareDiluted
Diluted shares (millions): WeightedAverageNumberOfDilutedSharesOutstanding

Balance sheet

Cash and equivalents: CashAndCashEquivalentsAtCarryingValue
Short-term investments: AvailableForSaleSecuritiesDebtSecuritiesCurrent
Total current assets: AssetsCurrent
Total assets: Assets
Total current liabilities: LiabilitiesCurrent
Long-term debt: not filed
Total liabilities: Liabilities
Stockholders’ equity: StockholdersEquity
Shares outstanding (millions): dei:EntityCommonStockSharesOutstanding

Cash flow statement

Operating cash flow: NetCashProvidedByUsedInOperatingActivities
Capital expenditures: PaymentsToAcquirePropertyPlantAndEquipment
Free cash flow (CFO − capex): not filed
Depreciation and amortization: DepreciationDepletionAndAmortization
Share repurchases: PaymentsForRepurchaseOfCommonStock
Dividends paid: not filed

The data

The statements on this page as files, generated November 4, 2026.

JSON file
/data/financials/DOCU.json